This is the third article of a four-part series that will also include an overview and articles further exploring the survey’s implications for product development and claims.
Most underwriting manuals don’t address testosterone and as such underwriting elevated testosterone levels can be murky.
Poor metabolic health is the primary cause of non-communicable diseases (NCD), which today make up over 74% of deaths globally.
Life insurance companies have a reputation for being something akin to an oil tanker – big, and slow. But their approach to incorporating generative AI (GenAI) into various functions of their businesses can hardly be claimed to be thus.
In their most recent white paper, RGA experts Guizhou Hu, Mark Ma, and Taylor Pickett use Milliman risk scores as examples to introduce two risk score accuracy concepts that have been widely documented and applied in statistical literature.
Data scientists from LexisNexis Risk Solutions examined mortality trends before and after the pandemic, especially as those trends pertained to underserved populations. The findings were presented during the Society for Insurance Research’s Annual Conference this week in Cincinnati.
Lauren Garfield explores the increased use of GLP-1 receptor agonist drugs to combat obesity and the potential impact on underwriting.
In late 2022 Gen Re Medical Directors first noticed bizarre ECGs present in PI files from primary insurers. These “perfect” ECGs were performed by paramedical examiners and included with facultative files for reinsurance coverage. Initially they were very rare, but we have seen them become more common.
This article provides background on bladder cancer, with a particular focus on current and in-development treatments for non-muscle-invasive disease.
Raynaud’s phenomenon (or Raynaud’s syndrome) can be part of a much more serious group of impairments which can affect the esophagus, skin and fingers, and progress to gangrene in its more severe form.